Literature DB >> 8731438

Altered mitochondrial membrane fluidity in AD brain.

P Mecocci1, A Cherubini, M F Beal, R Cecchetti, F Chionne, M C Polidori, G Romano, U Senin.   

Abstract

Oxidative damage on biological membranes has been proposed as a cause of the alterations observed in aging brain and, more severely, in Alzheimer's disease (AD). In this study we evaluated membrane fluidity of mitochondria extracted from different areas of normal and AD brains by means of fluorescence polarization technique. AD mitochondria showed a significant reduction of membrane fluidity compared to controls except in cerebellum. This might be caused by a greater lipid peroxidation of biological membranes, as suggested by in vitro experiments we performed to this purpose. From these results the possible role of oxidative stress in AD pathogenesis is supported.

Entities:  

Mesh:

Year:  1996        PMID: 8731438     DOI: 10.1016/0304-3940(96)12509-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

Authors:  Stefan Smesny; Susan Stein; Ingo Willhardt; Jürgen Lasch; Heinrich Sauer
Journal:  J Neural Transm (Vienna)       Date:  2008-06-27       Impact factor: 3.575

3.  Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release.

Authors:  A M Aleardi; G Benard; O Augereau; M Malgat; J C Talbot; J P Mazat; T Letellier; J Dachary-Prigent; G C Solaini; R Rossignol
Journal:  J Bioenerg Biomembr       Date:  2005-08       Impact factor: 2.945

4.  Changes in lipid composition in hippocampus early and late after status epilepticus induced by kainic acid in wistar rats.

Authors:  Felipe Dal-Pizzol; João Quevedo; Emílio Streck; Roger Walz; José Cláudio F Moreira
Journal:  Metab Brain Dis       Date:  2007-03       Impact factor: 3.584

5.  Mitochondria are related to synaptic pathology in Alzheimer's disease.

Authors:  Stavros J Baloyannis
Journal:  Int J Alzheimers Dis       Date:  2011-09-12

6.  Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin.

Authors:  Sergio A Rosales-Corral; Gabriela Lopez-Armas; Jose Cruz-Ramos; Valery G Melnikov; Dun-Xian Tan; Lucien C Manchester; Ruben Munoz; Russel J Reiter
Journal:  Int J Alzheimers Dis       Date:  2012-05-16

7.  Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin.

Authors:  Sergio Rosales-Corral; Dario Acuna-Castroviejo; Dun Xian Tan; Gabriela López-Armas; José Cruz-Ramos; Rubén Munoz; Valery G Melnikov; Lucien C Manchester; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2012-05-13       Impact factor: 6.543

8.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.

Authors:  Hindupur K Anandatheerthavarada; Gopa Biswas; Marie-Anne Robin; Narayan G Avadhani
Journal:  J Cell Biol       Date:  2003-04-14       Impact factor: 10.539

Review 9.  PPAR agonists as therapeutics for CNS trauma and neurological diseases.

Authors:  Shweta Mandrekar-Colucci; Andrew Sauerbeck; Phillip G Popovich; Dana M McTigue
Journal:  ASN Neuro       Date:  2013-12-18       Impact factor: 4.146

10.  Metabolomics profiling reveals novel markers for leukocyte telomere length.

Authors:  Jonas Zierer; Gabi Kastenmüller; Karsten Suhre; Christian Gieger; Veryan Codd; Pei-Chien Tsai; Jordana Bell; Annette Peters; Konstantin Strauch; Holger Schulz; Stephan Weidinger; Robert P Mohney; Nilesh J Samani; Tim Spector; Massimo Mangino; Cristina Menni
Journal:  Aging (Albany NY)       Date:  2016-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.